October 19, 2022 02:14 PM EDT
Pharma

Mer­ck KGaA's French af­fil­i­ate in­dict­ed over in­ves­ti­ga­tion in­to re­for­mu­la­tion case

Zachary Brennan

Senior Editor

Last March, the top court in France or­dered Ger­many-based Mer­ck KGaA to pay out more than $3.6 mil­lion to more than 3,000 peo­ple to set­tle …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Jim Wilson's Gem­ma­Bio rais­es $34M to com­mer­cial­ize gene ther­a­pies for rare dis­eases

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times